Cosmetic Surgery Times:
Having trouble viewing this e-mail? Click here.
 
Cosmetic Surgery Times E-News
Modern Medicine Network
TOP SEARCHES: Lasers & Technology // Liposuction // Facelift
In this issue
Sculptra results positive
Medicis ships fillers
Cambodia: Surgery a danger
Valeant to market Refissa
Key Topic Updates
 
 
CST Radio

  Become a Fan of CST on Facebook

  Follow CST on Twitter
Contact Us
Click here to contact a Cosmetic Surgery Times editor.

Click here to contact a Cosmetic Surgery Times sales representative.

Click here to learn about direct mail, reprints and classifieds in Cosmetic Surgery Times.

MARCH 10, 2010
Interim results of Artefill study ‘encouraging’
San Diego — There are encouraging 18-month interim results from a prospective five-year safety and patient-satisfaction study on Artefill (collagen gel/polymethylmethacrylate, Suneva Medical) for use in correcting nasolabial folds, PR Newswire reports. More...
Study: Sculptra performs well in nasolabial folds
Bridgewater, N.J. — Recently released results of a new study suggest that treatment with Sculptra Aesthetic (poly-L-lactic acid, Sanofi-Aventis) was significantly more effective than the human-derived collagen treatment CosmoPlast in correcting shallow to deep nasolabial folds, PR Newswire reports. More...
Medicis ships Restylane, Perlane after FDA nod
Scottsdale, Ariz. — Medicis, based here, has begun shipment of the dermal fillers Restylane-L and Perlane-L (both hyaluronic acid/lidocaine), GlobeNewswire reports. More...
Cambodia warns of non-licensed cosmetic surgeons
Phnom Penh, Cambodia — Cambodian Prime Minister Hun Sen has warned women to beware of dubious standards in the country’s booming cosmetic surgery industry, as doctors often practice without a license, Bangkokpost.com reports. More...
Valeant secures rights to market Refissa
Aliso Viejo, Calif. — Valeant Pharmaceuticals International, based here, has entered into an agreement with Spear Pharmaceuticals, Fort Myers, Fla., for the rights to commercialize Refissa (tretinoin cream, USP [emollient] 0.05 percent), a prescription topical cream used to treat fine wrinkles and irregular pigmentation due to sun damage, PR Newswire-FirstCall reports. More...
Key Topic Updates  
Liability & Risk Management
Peer review process exempt from antitrust laws
Use caution when altering medical records
Personal Finance
Maximizing charitable contributions
Physician’s Focus: Tax Day 2010 is approaching
Healthcare IT
Doctors more likely to report drug side effects electronically
Truncated information mandated for patient receipts
Career Opportunities
Premiere Center for Cosmetic Surgery
BC/BE Plastic Surgeon
Sleek MedSpa
Seeking Plastic Surgeons
Star Medical Group, P.C.
Experienced Plastic Surgeon(s)
The Bassin Center for Plastic Surgery
Oculoplastic Fellowship

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.